Wei Lin

机构：South China Agricultural University, Fujian Medical University, Wenzhou Medical University, Fuzhou University · ORCID：0000-0002-0455-8752

发表论文 150 篇 · 总被引 1475 次 · h-index 20

代表论文

• Preliminary safety, antitumor activity, and circulating tumor DNA (ctDNA) changes with RMC-9805, an oral, RAS(ON) G12D-selective tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 36)
• Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study (2025 · Respiratory Research · 被引 20)
• Developing a rapid screening tool for high-risk ICU patients of sepsis: integrating electronic medical records with machine learning methods for mortality prediction in hospitalized patients—model establishment, internal and external validation, and visualization (2025 · Journal of Translational Medicine · 被引 14)
• Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: A Systematic Review and Meta-Analysis (2025 · Endocrine Practice · 被引 10)
• Integrative Machine Learning Approach for Predicting Resistance to First-generation Receptor Ligands in Acromegaly (2025 · The Journal of Clinical Endocrinology & Metabolism · 被引 6)
• Metabolic complications and clinical outcomes of non-functioning adrenal incidentalomas: a systematic review and meta-analysis (2025 · BMC Endocrine Disorders · 被引 3)